Announcements Trials
Browse Landscape

Phase

Phase NA 31Phase 3 4Phase 2 2Phase 4 1

Status

Completed 2

Sponsor Class

OTHER_GOV 1OTHER 1

Study Type

Interventional 2

Sponsor

Cancer Type

Breast 2

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 2Leukemia, Myeloid, Acute 2Heart Failure 2Breast Neoplasms 2Stomach Neoplasms 1Rectal Neoplasms 1Postoperative Complications 1Pheochromocytoma 1Pain, Postoperative 1Neoplasms 1Locally Advanced Head and Neck Squamous Cell Carcinoma 1Jaw Cysts 1Gastrointestinal Stromal Tumors 1Arrhythmias, Cardiac 1Agnosia 1

Interventions

Trastuzumab 303Paclitaxel 256Cyclophosphamide 251Docetaxel 238Capecitabine 175Letrozole 163Carboplatin 163Doxorubicin 145Fulvestrant 144Bevacizumab 121Anastrozole 106Tamoxifen 102exemestane 94Vinorelbine 91Epirubicin 90pertuzumab 88Gemcitabine 84Lapatinib 80Albumin-Bound Paclitaxel 74Radiotherapy 71pembrolizumab 70palbociclib 64130-nm albumin-bound paclitaxel 58eribulin 56Cisplatin 55Everolimus 49pyrotinib 44Taxes 44Goserelin 43Neoadjuvant Therapy 40

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

2 trials
RecentStart dateEnrollment
Phase 2 × Breast Neoplasms × Control Groups × Clear all
NCT07081581 2025-07-23

Analgesic Effect of Serratus Plane Block With Adjuvant Agents in Breast Cancer Surgery

Sultan Abdulhamid Han Training and Research Hospital, Istanbul, Turkey

Phase 2 Completed
75 enrolled
Breast

Agnosia, Breast Neoplasms, Pain, Postoperative

NCT04222790 2023-12-04

A Study of Monosialic Gangliosides to Prevent Albumin-bound Paclitaxel Neurotoxicity

Henan Cancer Hospital

Phase 2 Completed
159 enrolled
Breast

Breast Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡